Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Scroll Top
suz015f1

How important is microcirculation in clinical practice?

This study explores the microcirculation in patients with acute heart failure (AHF) and cardiogenic shock (CS). It highlights the importance of evaluating microcirculatory function alongside traditional hemodynamic measures in these patients.

Microcirculatory dysfunction, characterized by impaired blood flow at the capillary level, is linked to poorer outcomes in AHF and CS. The study suggests that interventions targeting microcirculation could potentially enhance patient outcomes in these conditions. In summary, understanding and addressing microcirculatory dysfunction is crucial for managing AHF and CS effectively.

Read the full study: https://academic.oup.com/eurheartjsupp/article/21/Supplement_B/B25/5422922


(side note)

Acute heart failure (AHF) is a condition characterized by a sudden onset or worsening of symptoms related to the heart’s inability to pump blood effectively. This can lead to a buildup of fluid in the lungs and other tissues, causing symptoms such as shortness of breath, fatigue, and swelling in the legs and ankles. AHF can be caused by various factors, including heart attack, infections, arrhythmias, high blood pressure, or underlying heart conditions.

The diagnosis of AHF is based on a combination of clinical symptoms, physical examination, and diagnostic tests such as echocardiography and blood tests. Treatment aims to alleviate symptoms, improve heart function, and address the underlying cause. It may include medications such as diuretics to remove excess fluid, vasodilators to relax blood vessels, inotropic agents to strengthen heart contractions, and oxygen therapy to improve oxygenation.

In severe cases, AHF can lead to cardiogenic shock, a life-threatening condition where the heart’s pumping function is severely compromised, necessitating urgent medical intervention. Long-term management of AHF often involves lifestyle modifications, medication adherence, and regular follow-up with healthcare providers to prevent future episodes and complications.

Related Posts

Leave a comment

You must be logged in to post a comment.